DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20205614

Practice pattern and use of serum peptide formulation in patients with alopecia: results of an opinion survey among dermatologists in India

Rekha Lanjekar

Abstract


To evaluate practice pattern and preference for use of serum peptide formulation by dermatologists for the treatment of alopecia. Dermatologists in India were administered a questionnaire consisting of questions related to number of patients with alopecia seen every week, investigations, prevalence of nutritional deficiencies and use of serum peptide formulation in telogen effluvium (TE) and androgenetic alopecia (AGA). The responses were analysed as number and percentages. Out of 124 dermatologists, 38 (31%) reported that they see 11-15 patients with TE every week and 31 (25%) reported seeing 11-15 patients of AGA per week. According to 51 (41%) dermatologists, 40-60% patients with hair loss have some nutritional deficiency and 95 (77%) reported that iron deficiency profile, thyroid stimulating hormone (TSH), vitamin B1 and vitamin D level estimation is necessary in patients with TE. A total of 86 (69%) dermatologists preferred serum peptide formulation in patients with TE and AGA. Ninety nine (80%) and 75 (60%) dermatologists reported “very good” or “good” efficacy of serum peptide in TE and AGA respectively. Ninety nine (80%) dermatologists said, gender is not an important criterion for choosing a serum peptide in hair fall. For aesthetics related parameters, Folliserum (Abbott Health care Pvt Ltd) was rated as “Very good” and “Good” by 66 (53%) and 38 (31%) dermatologists respectively. According to dermatologists in India, nutritional deficiency is common in patients with alopecia. Majority of the survey participants rated Folliserum as “Very good” or “Good” for its efficacy and aesthetic parameters. 


Keywords


Androgenic alopecia, Serum peptide, Telogen effluvium

Full Text:

PDF

References


Phillips TG, Slomiany WP, Allison R. Hair loss: Common causes and treatment. Am Fam Physician. 2017;96:371-8.

Pratt CH, King LE, Messenger AG, Christiano AM, Sundberg JP. Alopecia areata. Nat Rev Dis Primers. 2017;3:17011.

Shrivastava SB. Diffuse hair loss in an adult female: approach to diagnosis and management. Indian J Dermatol Venereol Leprol. 2009;75:20-7.

Lee WS, Lee HJ. Characteristics of androgenetic alopecia in Asian. Ann Dermatol. 2012;24:243-52.

Salman KE, Kucukunal NA, Altunay IK, Cerman AA. Frequency, severity and related factors of androgenetic alopecia in dermatology outpatient clinic: hospital-based cross-sectional study in Turkey. An Bras Dermatol. 2017;92:35-40.

Shapiro J, Wiseman M, Lui H. Practical management of hair loss. Can Fam Physician. 2000;46:1469-77.

Perera E, Sinclair R. Treatment of chronic telogen effluvium with oral minoxidil: A retrospective study. F1000Research. 2017;6:1650.

Santos Z, Avcil P, Hamblin MR. Drug discovery for alopecia: gone today, hair tomorrow. Expert Opin Drug Discov. 2015;10:269-92.

Rele AS, Mohile RB. Effect of mineral oil, sunflower oil, and coconut oil on prevention of hair damage. J Cosmet Sci. 2003;54:175-92.

Almohanna HM, Ahmed AA, Tsatalis JP, Tosti A. The role of vitamins and minerals in hair loss: A review. Dermatol Ther (Heidelb). 2019;9:51-70.

Goluch-Koniuszy ZS. Nutrition of women with hair loss problem during the period of menopause. Menopause Rev. 2016;15:56-61.

Thompson JM, Mirza MA, Park MK, Qureshi AA, Cho E. The role of micronutrients in alopecia areata: A Review. Am J Clin Dermatol. 2017;18:663-79.

Hosking A-M, Juhasz M, Mesinkovska NA. Complementary and alternative treatments for alopecia: A comprehensive review. Skin Appendage Disord. 2019;5:72-89.

Artantas S, Gul U, Kilic A, Guler S. Skin findings in thyroid diseases. Eur J Intern Med. 2009;20:158-61.

Dinh QQ, Sinclair R. Female pattern hair loss: Current treatment concepts. Clin Interven Aging. 2007:2:189-99.

Gowda D, Premalatha V, Imtiyaz DB. Prevalence of nutritional deficiencies in hair loss among indian participants: Results of a cross-sectional study. Int J Trichol. 2017;9:101-4.

Gajjar PC, Mehta HH, Barvaliya M, Sonagra B. Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male: a randomized controlled trial. Int J Trichol. 2019;11:58-67.

Grover C, Khurana A. Telogen effl uvium. Indian J Dermatol Venereol Leprol. 2013;79:591-603.